3D Tissue Models

Cancer Biology: Amgen

Total Score People Score Events Score
32 27 25
Date Event Presentation Speakers
February 11, 2014 Jagelman/Turnbull International Colorectal Disease Symposium Mental conditioning in surgical education R. Scott Rosenthal
January 31, 2013 11th Cytokines and Inflammation Modeling the Distinct Roles for IL-23 and IL-17 in Inflammatory Bowel Disease Using mdr1a-/- Mice Jennifer Towne
September 12, 2010 Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR Title to be announced David Lacey
August 10, 2010 The International Quantitative Imaging Cytometry Centers of Excellence Provide a Forum for Educational and Training Programs in Quantitative Imaging Cytometry, with a Specific Focus on Solid-Phase Laser Scanning Imaging Cytometry Leveraging Quantitative Imaging Cytometry to Measure the Pharmacodynamic Impact of Drugs in Development Gloria Juan
May 19, 2010 Pre-Clinical / Clinical Development of Therapeutic Antibodies Translational Safety for Therapeutic Antibodies: Protecting Subjects and Enabling Risk:Benefit Decisions During Early Clinical Development Andrew Erdman
Targeting GPCRs with Therapeutic Antibodies Hai Yan
August 5, 2009 New Frontiers in Cancer Drug Development AMG 386, an Anti-Angiogenic Agent Targeting the Angiopoietin-Tie2 Pathway Jon Oliner
Biomarker Clinical Utility: How Can Qualification of a Biomarker's Clinical Utility Be Determined? Prospective or Retrospective or a Combination? Scott D Patterson
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Ligands of Orphan GPCRs Identified from Inducible Expression of the Receptors and Cell-based Reporter Screen Paul Lee
August 3, 2009 The Next Wave of Antibody Therapeutics Pharmacodynamic Biomarkers of Antibodies Frank Calzone
Combinatorial Strategies for Tumor Inhibition using AMG 479, a Fully Human Monoclonal Antibody that Inhibits the Insulin-like Growth Factor (I) Receptor (IGF-1R) Frank Calzone
June 9, 2009 RNAi for Target Identification and Validation A Framework for the Analysis of RNAi Phenotypes as Quantitative Traits Kim Quon
June 9, 2009 Cell and Tissue-Based Assays for HTS Killing One Bird with Two Stones - A Platform for Testing Putative Anti-Cancer Agents in Combination using Cell-Based Assays Sharon Zhao
June 8, 2009 Genotyping Tools Significant Gene Content Variation Characterizes the Genomes of Inbred Mouse Strains Paul D. Kassner
June 8, 2009 RNAi for Functional Screens OPTIMIZING RNAi DELIVERY FOR IN VITRO APPLICATIONS Paul D. Kassner
March 9, 2009 Drug Development Latin America NFORMAL BREAK-OUT ROUNDTABLES Fidela Li Moreno
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics An Overview of the Bioanalysis of Protein Therapeutics Binodh DeSilva
Clinical Assessment of Neutralizing Antibodies to Protein Therapeutics Michele S. Swanson
Successful Development of Biotherapeutics: Scientific and Regulatory Strategies and Hurdles for Toxicology and ADME/PK Paul Pearson
Toxicology Study Strategies for Biopharmaceuticals in Comparison to Small Molecules Mary Ellen Cosenza
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Panelists Frank Calzone
March 25, 2008 Clinical Trials Asia Country and Site Selection for Global Clinical Trials Fidela Li Moreno
March 25, 2008 Preclinical Development Imaging Biomarkers in Early Clinical Development of Novel Therapeutic Agents Jeffrey Evelhoch
March 25, 2008 TRANSLATIONAL MEDICINE Imaging Biomarkers in Early Clinical Development of Novel Therapeutic Agents Jeffrey Evelhoch
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic In Vivo Imaging in Early Drug Development Jeffrey Evelhoch
November 15, 2007 Second Annual Drug Development India : Planning and Managing Drug Discovery & Development Activities Nov(15-16) CONTRIBUTION OF ACADEMIC INSTITUTES (13:30-15:00) Erich Wohlhieter
CONTRIBUTION OF ACADEMIC INSTITUTES: INTERACTIVE PANEL Supply Chain Challenges and Solutions to Reduce Cycle Time (14:20-15:00) Erich Wohlhieter
CLINICAL DEVELOPMENT AND OPERATIONS: INTERACTIVE PANEL:Outsourcing Globally and Executing International Trials in India (14:00-14:45) Mamata Gokhale
CLINICAL DEVELOPMENT AND OPERATIONS: Strategic Planning for Clinical Development Operations in India: Short and Long Term Barriers to Overcome (11:15-11:45) Mamata Gokhale
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Assessing Structure/Function Relationships (08:15-10:45) Xu-Rong Jiang
Assessing Structure/Function Relationships :Development and Validation of Rapid Homogeneous Quantitative Potency Assays for Biotech Products (08:15-08:45) Xu-Rong Jiang
Chairperson's Opening Remarks (08:00-08:15) Carol Hasselbacher
Stability Indicating Methods and Interpretation of Stability Data for Biotech Products (09:15-12:15) Carol Hasselbacher
Stability Indicating Methods and Interpretation of Stability Data for Biotech Products: Use of Forced Degradation Studies in Development of Product Stability Programs (10:45-11:15) Carol Hasselbacher
October 15, 2007 Cambridge Healthtech Institute's Third Annual Mastering Process Chemistry Oct (15-17) CASE STUDIES OF PRACTICAL SYNTHESIS (13:30-18:30) Oliver Thiel
CASE STUDIES OF PRACTICAL SYNTHESIS: Practical Synthesis of TRPV1 Antagonists for Treatment of Pain (14:10-14:40) Oliver Thiel
September 30, 2007 Bridging Pharma and IT - Leveraging Information Technology to Improve Productivity (Sep30-Oct2) Pre-Conference Workshop: Bridging Business and IT to Implement Performance Metrics (12:30-4:00) Paul King
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Pre-Conference Workshops; Biomarker Assay Development and Validation: Part I Tutorial FIT-FOR-PURPOSE BIOMARKER ASSAY DEVELOPMENT AND VALIDATION (08:00-12:00) Jean W Lee
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.